{
  "precision": 0.6666666666666666,
  "recall": 0.8,
  "macro_F1": 0.7272727272727273,
  "micro_F1": 0.7083333333333334,
  "accuracy": 0.5,
  "correct_cases": {
    "2566": [["lethal anuria", "ifosfamide"]],
    "2399": [["pulmonary toxicity", "gemcitabine"]],
    "1190": [
      ["localized panniculitis", "glatiramer acetate"],
      ["subcutaneous changes", "glatiramer acetate"]
    ]
  },
  "fail_cases": {
    "83": [
      ["human teratogen", "cyclophosphamide"],
      ["safety of cp in pregnancy", "cyclophosphamide"],
      ["distinct phenotype", "cyclophosphamide"]
    ],
    "475": [
      ["hepatitis", "sulphasalazine"],
      ["dermatitis", "sulphasalazine"],
      ["lymphadenopathy", "sulphasalazine"],
      ["fever", "sulphasalazine"]
    ],
    "2979": [["risk factor for the development of rs", "aspirin"]]
  },
  "missing_cases": {
    "83": [],
    "475": [["constellation of dermatitis", "sulphasalazine"]],
    "2979": [["rs", "aspirin"]]
  },
  "false_cases": {
    "83": [
      ["safety of cp in pregnancy", "cyclophosphamide"],
      ["distinct phenotype", "cyclophosphamide"]
    ],
    "475": [["dermatitis", "sulphasalazine"]],
    "2979": [["risk factor for the development of rs", "aspirin"]]
  },
  "responses": {
    "83": " [['human teratogen', 'cyclophosphamide'], ['distinct phenotype', 'cyclophosphamide'], ['safety of CP in pregnancy', 'cyclophosphamide']]\nExplanation: Cyclophosphamide is a human teratogen and can cause a distinct phenotype in pregnant women, raising serious safety concerns.",
    "2566": " [['lethal anuria', 'ifosfamide']]\nExplanation: High dose ifosfamide chemotherapy led to lethal anuria in a breast cancer patient with impaired renal function.",
    "475": " [['dermatitis', 'sulphasalazine'], ['fever', 'sulphasalazine'], ['lymphadenopathy', 'sulphasalazine'], ['hepatitis', 'sulphasalazine']]\nExplanation: The patient developed dermatitis, fever, lymphadenopathy, and hepatitis after taking oral sulphasalazine for sero-negative rheumatoid arthritis.",
    "2399": " [['pulmonary toxicity', 'gemcitabine']]\nExplanation: Gemcitabine can cause pulmonary toxicity, which is a dramatic condition.",
    "2979": " [['risk factor for the development of RS', 'aspirin']]\nExplanation: The use of aspirin during an antecedent illness was found to be a risk factor for the development of RS.",
    "1190": " [['subcutaneous changes', 'glatiramer acetate'], ['localized panniculitis', 'glatiramer acetate']]\nExplanation: The 46-year-old female patient developed subcutaneous changes and localized panniculitis after being treated with glatiramer acetate for 18 months."
  }
}
